PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1078107
PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1078107
Global STD Home Testing Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Others) by Sample Type (Blood-Based, Oral-Fluid Based, Urine Based, Other Body Fluid Based) Forecast 2022-2028
The global STD home testing market is anticipated to grow at a favourable CAGR of nearly 4.7% during the forecast period. The sexually transmitted diseases (STD), are infections transmitted that transfer from an infected person to an uninfected person through sexual contact and passed by blood or sexual fluids such as semen, or vaginal fluids, and can be transmitted by exchange of blood of an infected person. Some of the major types of STDs are herpes and HPV which are spread through other intimate physical contacts. The major factor that enhances the growth of the market, is the increasing intervention of central and state governments in the uptake of STD home testing t prevent the further spread of STDs, which is a key factor driving the growth of the global STD home testing market. According to the Center for Disease control and Prevention in 2019, a total of 1,808,703 cases of Chlamydia trachomatis infection were reported, making it the most common notifiable condition in the US, a total of 616,392 cases of gonorrhea were reported, and 129,813 cases of all stages of syphilis were reported, including 38,992 cases of primary and secondary (P&S) syphilis, the most infectious stages of the disease.
One of the prominent factor that restrained the growth of the global STD home testing, market are rise in the consumption of contraceptive daily pills and the taking of necessary precautions which reduced the spread of STDs among the people to some extent and thus decreases the STDs patients across the globe, which in turn reduces the STD testing, and thus hinders the growth of the market.
The STD home testing market is segmented based on disease and sample. Based on disease, the market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus (HPV), human immunodeficiency virus (HIV), and others. Based on sample type, the STD home testing market is segmented into blood-based, oral-fluid based, urine based, and other body fluid based. Based on disease, the herpes simplex virus segment is anticipated to grow at the fastest rate, the segment is mainly driven due to the growing burden of herpes simplex virus infections, including genital herpes across the globe, and increasing R&D activities especially in emerging economies boost the growth of the segment. According to the report published in June 2021, titled ' Epidemiology of herpes simplex virus type 2 in Asia: A systematic review, meta-analysis, and meta-regression', states that 1 in 10 persons are infected with herpes simplex virus type-2 infections, and the virus accounts for half of the genital ulcer diseases(GUD) and three-quarters of genital herpes cases.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.The European region is accounted for the highest share of the STDs testing market. The growth is augmented owing to the FDA approval testing devices and drugs for advanced sexually transmitted diseases, and presence of healthcare insurance companies to provide healthcare insurance and coverage for life, are the primary factor contributing to the market growth in the region.
The major companies serving the global STD home testing market are Biosure (UK), Ltd., Everlywell, Inc., JAL Medical (Singapore) Pvt Ltd., Mylab Discovery Solutions Pvt. Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Chiricahua Community Health Centers Inc., announced a collaboration with The Body Agency Collective(TBAC), and Visby Medical Inc., to improve sexually transmitted infections(STI). This test has come with the added benefits of being rapid, and it is easy to afford and accessible to rapid healthcare.
Research Methodology
The market study of the global STD home testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
Category- Medical Devices